Global Health Impact Fund: Recent Episodes
Martyn Eeles
Chad McClennan, the president and CEO of Koios Medical, discusses how their AI software, and Smart Ultrasound, is helping physicians in clinical practice.
The software streamlines workflow, reduces stress, and provides a confidence boost to clinicians when interpreting ultrasound exams.
The idea for Koios Smart Ultrasound came from physicians who wanted to improve the accuracy and efficiency of cancer diagnosis.
Koios Medical is a global company that works with various partners in the medical field. AI in the medical space is predicted to become standard of care in the next five years.
Takeaways
- Koios Medical Smart Ultrasound streamlines workflow and reduces stress for physicians in clinical practice.
- The software provides a confidence boost to clinicians when interpreting ultrasound exams.
- Koios Medical is a global company that works with various partners in the medical field.
- AI in the medical space is predicted to become standard of care in the next five years.
Summary
Dr. Faris El-Ramadani, a GP and clinical director in the UK, discusses the healthcare landscape and the role of technology in improving patient care. He explains that most clinical care in the UK is delivered through the National Health Service (NHS), with private sector involvement. The waiting times for NHS services have led to an increase in private health insurance. Dr. Faris highlights the patient journey through the NHS, starting with a visit to a general practitioner and potential referral to a specialist. He discusses the challenges of reducing waiting times and the need for both demand-side and supply-side changes. Dr. Faris also explains the structures within the NHS and how HealthTech can make an impact across primary and secondary care. He advises startups to understand their product, target audience, and messaging when approaching the NHS.
Takeaways
- Most clinical care in the UK is delivered through the NHS, with private sector involvement.
- Waiting times for NHS services have led to an increase in private health insurance.
- The patient journey through the NHS starts with a visit to a general practitioner and potential referral to a specialist.
- Reducing waiting times in the UK requires both demand-side and supply-side changes.
- HealthTech can make an impact across primary and secondary care in the NHS.
- Startups should understand their product, target audience, and messaging when approaching the NHS.
Chapters
00:00 Introduction and Background
01:19 Private vs. State Provision in the UK
04:08 Patient Journey through the NHS
06:58 Reducing Waiting Times in the UK
09:19 Structures within the NHS and the Role of HealthTech
13:58 Advice for Startups Working with the NHS
16:05 Conclusion
Summary
In this episode, Dr. Rajiv Sharma, a gastroenterologist and investor, discusses various topics related to the healthcare industry. He highlights the hottest specialty markets, including gastroenterology, orthopedic surgery, oncology, and rheumatology. Dr. Sharma also emphasizes the role of AI in healthcare, such as its use in colonoscopy procedures and data analysis. He discusses the growth of the pharmaceutical industry and the increasing demand for obesity care. Additionally, he explores the acceptance and potential of digital health and the importance of personalized medicine.
Takeaways
- Gastroenterology, orthopedic surgery, oncology, and rheumatology are among the hottest specialty markets in healthcare.
- AI is being used in healthcare for various purposes, including assisting in colonoscopy procedures and analyzing patient data.
- The pharmaceutical industry is expected to grow due to the aging population, increased global wealth, and rising demand for treatments.
- Obesity care is a growing market that requires innovation and personalized solutions.
- Digital health has the potential to improve access to care and enhance treatment outcomes.
- Personalized medicine, based on individual DNA and data analysis, can lead to better treatment outcomes and improve overall health.
Chapters
00:00 Introduction
01:29 Hottest Specialty Markets
03:53 AI in Healthcare
07:48 Pharmaceutical Industry Growth
10:11 Obesity Care
12:48 Digital Health
15:53 Personalized Medicine
16:21 Conclusion
Summary
In this episode, Martyn interviews Shona D'Arcy, the CEO of Kids Speech Labs, about the challenges and solutions in children's speech and language development.
The conversation focuses on the issue of long waiting times for speech therapy services and the importance of early intervention. Shona explains how Kids Speech Labs is addressing this problem by developing a triage system that allows for accurate assessment and personalized interventions. The discussion also touches on the challenges in community health, the potential of AI in speech therapy, and the need for innovation in this field.
Takeaways
- Long waiting times for children's speech therapy services can lead to missed opportunities for early intervention, which can have long-term impacts on a child's development.
- Kids Speech Labs is addressing the waiting list issue by developing a triage system that allows for accurate assessment and personalized interventions.
- Community health and allied health services often lag behind in digital transformation, leading to inefficiencies and low morale among healthcare professionals.
- AI has the potential to improve the early triage and screening process in speech therapy, enabling more targeted interventions and personalized care. Chapters
00:00 Introduction
01:00 The Issue of Waiting Times
02:02 Long-Term Impacts on Children
03:25 Addressing the Waiting Lists
05:20 Challenges in Community Health
06:46 The Role of AI in Speech Therapy
08:45 The Potential for Innovation
09:58 Expanding into New Markets
11:46 Closing Remarks
In this episode, Todd Otten discusses the power of one plus one and how it can empower individuals to disrupt the status quo in healthcare. He introduces the concept of the quadruple aim, which includes patient experience, quality care, lower costs, and provider wellness. Todd explains that implementing the power of one plus one can come from both top-down and bottom-up approaches within institutions. He emphasizes the importance of combating physician burnout and offers advice on how institutions can address this issue. Todd also shares details about his upcoming keynote presentation and encourages listeners to check out his book, 'Ripple of Change.'
www.Ourquadrupleaim.com
https://www.amazon.com/Ripple-Change-burned-out-frustrated-razor-sharp/dp/B0CG82D18N/ref=mp_s_a_1_1?keywords=ripple+of+change+otten&qid=1705094643&sr=8-1
Dr. Ashley Mak discusses the challenges of healthcare affordability, accessibility, and scaling in the context of physical therapy. He shares his early career realizations about the need for alternative care delivery models that can provide faster and more affordable care. Dr. Mak highlights the average waiting times for physical therapy and the impact of delayed care on patient suffering. We also explore the average cost of physical therapy and the importance of innovation while considering the costs of care. Additionally, Dr. Mak discusses current delivery models and upcoming technologies that can improve access and communication in healthcare.
In today's episode we talk with Rachna Dayal Goel, Global Director Transforming Customer Experience from Johnson & Johnson.
Introduction
You are in a big organization. How do still stay engaged with startups and the entrepreneurial world?
What advice would you have for startups wanting to work with big companies in healthcare industry
What are some industry specific points that you want entrepreneurs to keep in mind as they develop innovations and startups in this area?
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Rachna! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In today's episode we talk about what is precision medicine with an amazing guest and a true expert, Ella Li CEO of ZGC Capital and Founder of MedLabs
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Ella! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In today's episode we talk about Artificial Intelligence with an amazing expert in the medical field Dr. Michael Byrne, CEO and Founder of Satisfai Health.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Michael! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In today's episode we welcome back Dr. Alex Cahana. Listen to Alex discuss blockchain in the clinic plus can you earn additional revenue?
Wy should we use blockchain in my clinic or organization?
Can we earn additional revenue using blockchain?
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Alex! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In today's episode we have a true expert in Blockchain - Dr. Alex Cahana. Listen to Alex discuss blockchain and it's benefits it brings to health care.
What is Blockchain?
How can we leverage Blockchain to benefit Healthcare?
How can Blockchain be used in EHR?
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Alex! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In today's episode we introduce the Global Health Impact Network. You have heard us mention the network in previous episodes. So today our guest is Dr. Gary Goldman who is the founder of GHIF and GHIN.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Gary! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In today's episode we discuss GHIF Fund II our new international fund. We discuss what kind of startups we look for as well as what kind of partners we would like to work with to in addition to growing the network as well.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In this weeks episode we talk about how to become a VC as well as how to understand VC.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In this week's episode, we chat with Raja Sundaram Co-Founder of Plethy.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
In this week's episode, we hear a great pitch from Blake Richards CEO of Elucid. Followed by a Q&A and then a discussion between Martyn and Orrin
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario.
GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario.
GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in the capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement. This week we discuss the art of pitching
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario.
Our network isn’t a passive investor base – GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.
This week we discuss the importance of How To Source And Filter Companies. We cover everything from networking, events, partnerships, and many more.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. Our network isn’t a passive investor base – GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement. This week we discuss the importance of supporting a company post-investment. We cover everything from governance, fundraising, relationships, execution, executive coaching, and exit.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. Our network isn’t a passive investor base – GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement. This week we talk about what is due diligence and why it matters. What do investors look for in due diligence? Who does due diligence at a fund as well as how long the process takes? We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. Our network isn’t a passive investor base – GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement. In today's episode, we cover how to understand a cap table. We cover what is a cap table and why it matters. How cap tables are used and what is included. What do investors want to understand from your cap table as well as how to avoid mistakes in the cap table.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. Our network isn’t a passive investor base – GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement. What is the difference between a venture capital fund and a venture capital firm? Growth capital and seed capital. What is the difference between General Partner and Limited Partner, who in the organization runs the firm or the fund?
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.
Global Health Impact Fund (GHIF) is a Strategic Venture Capital Investment Network. Our investor-focused model invests exclusively on behalf of our clinician and healthcare professional investor network. We provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. Our network isn’t a passive investor base – GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. We care not just for your investment, but also for your opinions and participation. Our typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in capital, we have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement. The first episode covers how to become an investor. Understanding the differences between Angel investing or joining a Venture Capital Fund. Over the first 6 episodes, we will take you on a journey of how to become an investor and how to understand the different aspects of investing.
We would love to know what you took away from this conversation with Martyn and Orrin! Follow @martyneeles and give your insight and questions using the hashtag #GHIF. If you would like to be considered as a guest or have someone you would like to hear from (GP or LP), drop me a direct message on Twitter.